The biologics revolution: Navigating the past, present, and future of monoclonal antibodies in veterinary medicine
19 Nov 2026
Zoetis Learning Academy
Monoclonal antibodies have fundamentally shifted the therapeutic paradigm in human medicine and are now rapidly transforming the veterinary clinical landscape. This session provides a "One Health" exploration of the journey of biologics—from their intricate molecular development and mechanisms of action to their real-world application in the clinic. By drawing parallels between human breakthroughs and veterinary innovations, we will examine how targeted therapies are redefining the management of a number of chronic diseases. Special care will be taken to ensure this session will not be commercial in any way, and any mention of veterinary products will be based on their science with no commercial bias.
- •Define key mechanisms of action of monoclonal antibodies and apply them to clinical decision-making in veterinary practice.
- •Evaluate the utility of monoclonal antibodies in veterinary medicine, including long-term safety, cost-benefit analyses, and patient selection
- •Identify appropriate patients for monoclonal antibody therapy in the clinic
){kind=logo}
)
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
)
){kind=logo}
)
)
)
){kind=logo}
){kind=logo}
